Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report

J Med Case Rep. 2023 Jul 19;17(1):320. doi: 10.1186/s13256-023-04028-3.

Abstract

Background: Primary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is no specific treatment guideline has for carcinosarcoma of the bladder, and majority of published patients was treated exclusively by surgery.

Case presentation: We report a case of 65-year-old Moroccan man, presented with macroscopic hematuria, pollakiuria and painful urination. Histological analysis showed a biphasic epithelial and mesenchymal proliferation, with invasion of lamina propria and muscularis, compatible with diagnosis of bladder carcinosarcoma. The patient was treated with cystectomy and adjuvant chemotherapy based on gemcitabin-cisplatin, 18 months after treatment, patient still free of recurrence.

Conclusion: Carcinosarcoma of the urinary bladder is a rare and aggressive tumor regardless treatment. A multidisciplinary management based on radical cystectomy and combined adjuvant treatments can improve prognosis. In this work, we suggest to propose adjuvant chemotherapy whenever possible.

Keywords: Bladder carcinosarcoma; Chemotherapy; Cystectomy; Outcomes.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell* / pathology
  • Carcinosarcoma* / drug therapy
  • Carcinosarcoma* / pathology
  • Chemotherapy, Adjuvant
  • Cystectomy
  • Humans
  • Male
  • Pelvic Neoplasms* / surgery
  • Soft Tissue Neoplasms* / surgery
  • Urinary Bladder / diagnostic imaging
  • Urinary Bladder / pathology
  • Urinary Bladder / surgery
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / surgery